Literature DB >> 11530694

Industrial purification of pharmaceutical antibodies: development, operation, and validation of chromatography processes.

R L Fahrner1, H L Knudsen, C D Basey, W Galan, D Feuerhelm, M Vanderlaan, G S Blank.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11530694     DOI: 10.1080/02648725.2001.10648017

Source DB:  PubMed          Journal:  Biotechnol Genet Eng Rev        ISSN: 0264-8725


× No keyword cloud information.
  19 in total

1.  Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc.

Authors:  Ramil F Latypov; Sabine Hogan; Hollis Lau; Himanshu Gadgil; Dingjiang Liu
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

Review 2.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

3.  Cation-exchange chromatography of monoclonal antibodies: characterisation of a novel stationary phase designed for production-scale purification.

Authors:  Marina Urmann; Heiner Graalfs; Matthias Joehnck; Lothar R Jacob; Christian Frech
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 4.  The present state of the art in expression, production and characterization of monoclonal antibodies.

Authors:  Christopher L Gaughan
Journal:  Mol Divers       Date:  2015-08-25       Impact factor: 2.943

Review 5.  Industrialization of mAb production technology: the bioprocessing industry at a crossroads.

Authors:  Brian Kelley
Journal:  MAbs       Date:  2009-09-16       Impact factor: 5.857

6.  Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G.

Authors:  Shin Miyakawa; Yusuke Nomura; Taiichi Sakamoto; Yoshiki Yamaguchi; Koichi Kato; Satoko Yamazaki; Yoshikazu Nakamura
Journal:  RNA       Date:  2008-04-25       Impact factor: 4.942

7.  Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys.

Authors:  Maya K Leabman; Y Gloria Meng; Robert F Kelley; Laura E DeForge; Kyra J Cowan; Suhasini Iyer
Journal:  MAbs       Date:  2013 Nov-Dec       Impact factor: 5.857

8.  Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.

Authors:  Michael Logan; John Law; Jason Alexander Ji-Xhin Wong; Darren Hockman; Amir Landi; Chao Chen; Kevin Crawford; Juthika Kundu; Lesley Baldwin; Janelle Johnson; Anita Dahiya; Gerald LaChance; Joseph Marcotrigiano; Mansun Law; Steven Foung; Lorne Tyrrell; Michael Houghton
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 9.  RNA plasticity and selectivity applicable to therapeutics and novel biosensor development.

Authors:  Yoshikazu Nakamura; Akira Ishiguro; Shin Miyakawa
Journal:  Genes Cells       Date:  2012-04-04       Impact factor: 1.891

10.  Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex.

Authors:  Yusuke Nomura; Shigeru Sugiyama; Taiichi Sakamoto; Shin Miyakawa; Hiroaki Adachi; Kazufumi Takano; Satoshi Murakami; Tsuyoshi Inoue; Yusuke Mori; Yoshikazu Nakamura; Hiroyoshi Matsumura
Journal:  Nucleic Acids Res       Date:  2010-07-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.